The Pulse


Latest News

  • Arctic Therapeutics research suggests preventative strategy against HCCAA


  • The first blood test for Alzheimer’s has been approved in the USA, paving the way for earlier diagnosis and preventive…

  • Fujirebio’s FDA-approved Alzheimer’s blood test hailed as ‘game changer’

    The first blood test for Alzheimer’s has been approved in the USA, paving the way for earlier diagnosis and preventive treatment of the disease, FierceBiotech reported. The FDA has now green-lit the Lumipulse G test, developed by Fujirebio Diagnostics, for patients aged 55 and over who exhibit signs or symptoms of Alzheimer’s. Used alongside clinical…

Latest Insights

  • Fujirebio’s FDA-approved Alzheimer’s blood test hailed as ‘game changer’


  • Julie Holder

    Understanding dementia: Insights from a dementia nurse